Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 13

1.

A Randomized Comparison of Anthropomorphic Changes With Preferred and Alternative Efavirenz-Based Antiretroviral Regimens in Diverse Multinational Settings.

Erlandson KM, Taejaroenkul S, Smeaton L, Gupta A, Singini IL, Lama JR, Mngqibisa R, Firnhaber C, Cardoso SW, Kanyama C, Machado da Silva AL, Hakim JG, Kumarasamy N, Campbell TB, Hughes MD.

Open Forum Infect Dis. 2015 Jun 24;2(3):ofv095. doi: 10.1093/ofid/ofv095. eCollection 2015 Sep.

2.

Self-reported body fat change in HIV-infected men is a marker of decline in physical health-related quality of life with aging, independent of co-morbidity.

Erlandson KM, Reynolds SM, Cox C, Palella FJ, Witt MD, Kingsley LA, Brown TT, Plankey M.

PLoS One. 2014 Dec 1;9(12):e114166. doi: 10.1371/journal.pone.0114166. eCollection 2014.

3.

Metabolic abnormalities in adult HIV infected population on antiretroviral medication in Malaysia: a cross-sectional survey.

Hejazi N, Rajikan R, Choong CL, Sahar S.

BMC Public Health. 2013 Aug 15;13:758. doi: 10.1186/1471-2458-13-758.

4.

Obesity and dyslipidemia in South Asians.

Misra A, Shrivastava U.

Nutrients. 2013 Jul 16;5(7):2708-33. doi: 10.3390/nu5072708. Review.

5.

Rare adipose disorders (RADs) masquerading as obesity.

Herbst KL.

Acta Pharmacol Sin. 2012 Feb;33(2):155-72. doi: 10.1038/aps.2011.153. Review.

6.

New and emerging agents in the management of lipodystrophy in HIV-infected patients.

Bonnet E.

HIV AIDS (Auckl). 2010;2:167-78. doi: 10.2147/HIV.S13429. Epub 2010 Sep 17.

7.

Comparison of dorsocervical with abdominal subcutaneous adipose tissue in patients with and without antiretroviral therapy-associated lipodystrophy.

Sevastianova K, Sutinen J, Greco D, Sievers M, Salmenkivi K, Perttilä J, Olkkonen VM, Wågsäter D, Lidell ME, Enerbäck S, Eriksson P, Walker UA, Auvinen P, Ristola M, Yki-Järvinen H.

Diabetes. 2011 Jul;60(7):1894-900. doi: 10.2337/db11-0075. Epub 2011 May 20.

8.

Development of Buffalo Hump in the course of antiretroviral therapy including raltegravir and unboosted atazanavir: a case report and review of the literature.

Ceccarelli G, d'Ettorre G, Marchetti F, Rizza C, Mastroianni CM, Carlesimo B, Vullo V.

J Med Case Rep. 2011 Feb 17;5:70. doi: 10.1186/1752-1947-5-70.

9.

Lipoatrophy and lipohypertrophy are independently associated with hypertension.

Crane HM, Grunfeld C, Harrington RD, Kitahata MM.

HIV Med. 2009 Sep;10(8):496-503. doi: 10.1111/j.1468-1293.2009.00720.x. Epub 2009 May 20.

10.

Mitochondrial DNA haplogroups influence lipoatrophy after highly active antiretroviral therapy.

Hendrickson SL, Kingsley LA, Ruiz-Pesini E, Poole JC, Jacobson LP, Palella FJ, Bream JH, Wallace DC, O'Brien SJ.

J Acquir Immune Defic Syndr. 2009 Jun 1;51(2):111-6. doi: 10.1097/QAI.0b013e3181a324d6.

11.

Association of upper trunk and visceral adipose tissue volume with insulin resistance in control and HIV-infected subjects in the FRAM study.

Grunfeld C, Rimland D, Gibert CL, Powderly WG, Sidney S, Shlipak MG, Bacchetti P, Scherzer R, Haffner S, Heymsfield SB.

J Acquir Immune Defic Syndr. 2007 Nov 1;46(3):283-90.

12.

HIV-associated adipose redistribution syndrome (HARS): definition, epidemiology and clinical impact.

Lichtenstein K, Balasubramanyam A, Sekhar R, Freedland E.

AIDS Res Ther. 2007 Jul 16;4:16.

13.

HIV-associated adipose redistribution syndrome (HARS): etiology and pathophysiological mechanisms.

Lichtenstein K, Balasubramanyam A, Sekhar R, Freedland E.

AIDS Res Ther. 2007 Jun 27;4:14.

Items per page

Supplemental Content

Write to the Help Desk